A U.Okay. commerce group is because of raise its suspension of Novo Nordisk
A U.Okay. trade commerce group is because of raise a uncommon two-year suspension of Novo Nordisk over “severe breaches” selling an weight problems drug, however some teachers are elevating questions concerning the extent to which the general public will know if the corporate has substantively modified its enterprise practices.
The 2-year suspension was issued on March 16, 2023, by the Affiliation of British Pharmaceutical Trade after receiving a criticism alleging the corporate sponsored programs on weight administration on LinkedIn for well being professionals, with out making clear that it was concerned within the sponsorship. Since its Saxenda therapy is a weight reduction drug, the LinkedIn submit “seemed to be promotional,” the criticism acknowledged.
The Prescription Medicines Code of Observe Authority, a self-regulatory physique overseen by the commerce group, agreed and famous it was “very involved that Novo Nordisk didn’t acknowledge that this was a large-scale Saxenda promotional marketing campaign, which Novo Nordisk knowingly paid for and which was disguised.” Because of this, Novo was discovered to have violated seven voluntary codes of follow and discredited the trade.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
